Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday_老虎社区_美港股上老虎

Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday

Benzinga2021-12-20

Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.

Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.

Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).

ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.

The company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.

Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.

The company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.

Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

May808
·2021-12-20
In Cathy we trust
回复
1
举报
Foured
·2021-12-20
Let’s go G
回复
2
举报
收起
- Foured:
  Ok
  2021-12-20
  回复
  举报
CokeNBeer
·2021-12-20
Now?
回复
2
举报
CokeNBeer
·2021-12-20
Yeah
回复
3
举报
Tj23
·2021-12-20
Wow
回复
5
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1155454954?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-20 15:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155454954","market":"us","top_or_hot":-1,"title":"Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday","media":"Benzinga","content":"<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n2021-12-20 15:53 北京时间&nbsp;&nbsp;&nbsp;<strong>Benzinga</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a ...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QSI","symbol_name":"Quantum-Si Inc.","start_time":0,"source_url":null,"article_id":"1155454954","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155454954","pubTimestamp":1639986818,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"QSI":"Quantum-Si Inc."},"translate_title":"凯茜·伍德增持这家医疗技术公司的股份，该公司股价周五飙升6%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"QSI":0.9},"content_text":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.\nArk Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).\nARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.\nThe company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.\nQuantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.\nThe company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.\nQuantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":693819333,"gmtCreate":1639998790545,"gmtModify":1639998807875,"author":{"id":"4091627897322240","authorId":"4091627897322240","name":"May808","avatar":"https://static.tigerbbs.com/e7814d9dbbebfd7d55db30062d9856e7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4091627897322240","authorIdStr":"4091627897322240"},"htmlText":"In Cathy we trust","listText":"In Cathy we trust","text":"In Cathy we trust","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693819333","repostId":1155454954,"repostType":4,"repost":{"id":"1155454954","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639986818,"share":"https://www.laohu8.com/m/news/1155454954?lang=&edition=full","pubTime":"2021-12-20 15:53","market":"us","language":"en","title":"Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1155454954","media":"Benzinga","summary":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0","content":"<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-20 15:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155454954","content_text":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.\nArk Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).\nARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.\nThe company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.\nQuantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.\nThe company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.\nQuantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693143962,"gmtCreate":1639991715741,"gmtModify":1639991716217,"author":{"id":"3563577781679506","authorId":"3563577781679506","name":"Foured","avatar":"https://static.tigerbbs.com/1186b61f5b04203ae75a2949bd647713","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3563577781679506","authorIdStr":"3563577781679506"},"htmlText":"Let’s go G","listText":"Let’s go G","text":"Let’s go G","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693143962","repostId":1155454954,"repostType":4,"repost":{"id":"1155454954","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639986818,"share":"https://www.laohu8.com/m/news/1155454954?lang=&edition=full","pubTime":"2021-12-20 15:53","market":"us","language":"en","title":"Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1155454954","media":"Benzinga","summary":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0","content":"<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-20 15:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155454954","content_text":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.\nArk Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).\nARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.\nThe company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.\nQuantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.\nThe company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.\nQuantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7053699,"gmtCreate":1639991722962,"gmtModify":1639991722991,"authorId":3563577781679506,"author":{"id":3563577781679506,"idStr":"3563577781679506","authorId":3563577781679506,"name":"Foured","avatar":"https://static.tigerbbs.com/1186b61f5b04203ae75a2949bd647713","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693143962,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"}],"langContent":"CN"},{"id":693151046,"gmtCreate":1639990915980,"gmtModify":1639990916260,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"htmlText":"Now?","listText":"Now?","text":"Now?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693151046","repostId":1155454954,"repostType":4,"repost":{"id":"1155454954","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639986818,"share":"https://www.laohu8.com/m/news/1155454954?lang=&edition=full","pubTime":"2021-12-20 15:53","market":"us","language":"en","title":"Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1155454954","media":"Benzinga","summary":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0","content":"<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-20 15:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155454954","content_text":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.\nArk Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).\nARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.\nThe company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.\nQuantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.\nThe company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.\nQuantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693153769,"gmtCreate":1639990899970,"gmtModify":1639990900299,"author":{"id":"3581722811684208","authorId":"3581722811684208","name":"CokeNBeer","avatar":"https://static.tigerbbs.com/d83481d848bfcbe3dc2d701ebc1e6ce0","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3581722811684208","authorIdStr":"3581722811684208"},"htmlText":"Yeah&nbsp;","listText":"Yeah&nbsp;","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693153769","repostId":1155454954,"repostType":4,"repost":{"id":"1155454954","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639986818,"share":"https://www.laohu8.com/m/news/1155454954?lang=&edition=full","pubTime":"2021-12-20 15:53","market":"us","language":"en","title":"Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1155454954","media":"Benzinga","summary":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0","content":"<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-20 15:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155454954","content_text":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.\nArk Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).\nARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.\nThe company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.\nQuantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.\nThe company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.\nQuantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693162323,"gmtCreate":1639987861820,"gmtModify":1639987862258,"author":{"id":"3571780042589602","authorId":"3571780042589602","name":"Tj23","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3571780042589602","authorIdStr":"3571780042589602"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693162323","repostId":1155454954,"repostType":4,"repost":{"id":"1155454954","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639986818,"share":"https://www.laohu8.com/m/news/1155454954?lang=&edition=full","pubTime":"2021-12-20 15:53","market":"us","language":"en","title":"Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=1155454954","media":"Benzinga","summary":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,0","content":"<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Added To Stake In This Medical Technology Company As Its Shares Surged 6% On Friday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-20 15:53</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Cathie Wood</b>’s<b>Ark Investment Management</b>&nbsp;on Friday bought 26,126 shares — estimated to be worth $163,026 — in&nbsp;<b>Quantum-Si Inc</b>.</p>\n<p>Shares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.</p>\n<p>Ark Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund&nbsp;<b>Ark Genomic Revolution ETF</b>(BATS:ARKG).</p>\n<p>ARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si&nbsp;ahead of Friday’s trade.</p>\n<p>The company&nbsp;went public earlier this year in a SPAC merger with&nbsp;<b>HighCape Capital Acquisition Corp</b>.</p>\n<p>Quantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.</p>\n<p>The company is led by Dr. Jonathan Rothberg, who is also the founder of&nbsp;<b>Butterfly Network Inc</b>, a company backed by&nbsp;<b>Microsoft Corp</b>. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.</p>\n<p>Quantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QSI":"Quantum-Si Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155454954","content_text":"Cathie Wood’sArk Investment Management on Friday bought 26,126 shares — estimated to be worth $163,026 — in Quantum-Si Inc.\nShares of the medical technology company closed 6.12% higher at $6.24 a share. The stock is down 40.5% year-to-date.\nArk Invest has been piling up shares in the Guilford, Connecticut-based medical technology company via its flagship healthcare fund Ark Genomic Revolution ETF(BATS:ARKG).\nARKG held 11.36 million shares — worth $66.8 million — in Quantum-Si ahead of Friday’s trade.\nThe company went public earlier this year in a SPAC merger with HighCape Capital Acquisition Corp.\nQuantum-Si created the first next-gen protein sequencing platform with the goal of revolutionizing the field of proteomics. A commercial launch for Quantum-Si is scheduled for 2022 beginning with research use. The company will start by decoding the molecules of life starting with proteins with the potential to expand the scale to genomics.\nThe company is led by Dr. Jonathan Rothberg, who is also the founder of Butterfly Network Inc, a company backed by Microsoft Corp. Rothberg founded over 10 companies and is an award winner in the technology and medical fields.\nQuantum-Si is targeting a $21 billion market and believes it has a scalable semiconductor that could expand to home testing sometime after the year 2024. Applications for the chips from Quantum-Si could include diagnostic applications and drug discovery.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":19,"commentSize":5,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}